The economic costs of severe anaphylaxis in France: An inquiry carried out by the Allergy Vigilance Network

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 63, Issue 3, 2008, Pages 360-365

  Flabbee, J ^a,b   Petit, N ^a,b   Jay, N ^c   Guenard L ^a,b   Codreanu, F ^a,b   Mazeyrat, R ^a   Kanny, G ^a,b   Moneret Vautrin, D A ^a,b  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b Research Team 3399: Allergic Diseases: Diagnosis and Therapeutics   (France)

^c Hopital Saint Julien Nancy   (France)

Author keywords

Anaphylaxis; Cost; Drug; Food; Hymenoptera

Indexed keywords

ANAPEN; BETAMETHASONE; DESLORATADINE; PREDNISOLONE 3 SULFOBENZOATE; SALBUTAMOL; UNCLASSIFIED DRUG; VACCINE;

ABSENTEEISM; ADULT; ANAPHYLAXIS; ARTICLE; CHILD; CLINICAL ARTICLE; DEATH; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; ECONOMIC ASPECT; FATALITY; FEMALE; FOOD ALLERGY; FRANCE; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYMENOPTERA; IMMUNOTHERAPY; INTERNATIONAL CLASSIFICATION OF DISEASES; LAW SUIT; LONG TERM CARE; MAINTENANCE THERAPY; MALE; MEDICAL RECORD; MEDICAL SERVICE; MILK; PERIOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; WORK;

ADOLESCENT; ADULT; ANAPHYLAXIS; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DIRECT SERVICE COSTS; FEMALE; FRANCE; HEALTH CARE COSTS; HOSPITAL COSTS; HUMANS; MALE; MIDDLE AGED; PRIMARY PREVENTION; SEVERITY OF ILLNESS INDEX; SKIN TESTS;

EID: 38949105483     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2007.01513.x     Document Type: Article

References (51)

1. Sampson HA. Symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol 2005 115 : 584 591.
2. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr., Bock SA, Branum A et al. Second symposium of the definition and management of anaphylaxis: summary report - Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006 117 : 391 397.
3. Ring J, Brockow K, Behrendt H. History and classification of anaphylaxis. Novartis Found Symp 2004 257 : 6 16.
4. Stewart AG, Ewan W. The incidence, aetiology and management of anaphylaxis presenting to an accident and emergency department. Q J Med 1996 89 : 859 864.
5. Brown A, Mc Kinnon D, Chu K. Emergency department anaphylaxis: a review of 142 patients in a single year. J Allergy Clin Immunol 2001 108 : 861 866.
6. Pastorello E, Rivolta F, Bianchi M, Mauro M, Pravettoni V. Incidence of anaphylaxis in the emergency of a general hospital in Milan. J Chromatol B Biomed Sci Appl 2001 108 : 11 17.
7. Bellou A, Manel J, Samman-Kaakaji H, de Korwin JD, Moneret-Vautrin DA, Bollaert PE et al. Spectrum of acute allergic diseases in an emergency department: an evaluation of one's year experience. Emerg Med 2003 15 : 341 347.
8. Helbling A, Hurni T, Mueller UR, Pichler WJ. Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940,000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy 2004 34 : 285 290.
9. Mullins RJ. Anaphylaxis: risk of recurrence. Clin Exp Allergy 2003 33 : 1033 1040.
10. Moneret-Vautrin DA, Kanny G. L'Anaphylaxie alimentaire, nouvelle enquête multicentrique Française. Bull Acad Natl Med 1995 179 : 161 172.
11. Moneret-Vautrin DA, Morisset M, Flabbee J, Beaudouin E, Kanny G. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 2005 60 : 443 451.
12. Pumphrey R. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000 30 : 1144 1150.
13. Pumphrey RS. Fatal anaphylaxis in the UK, 1992-2001 Novartis Found Symp 2004 257 : 116 128 (discussion 128-132, 157-160, 276-285).
14. Lee SM. Biphasic anaphylactic reactions in pediatrics. Pediatrics 2000 106 : 762 766.
15. Sheikh A, Alves B. Hospital admissions for acute anaphylaxis: time trend study. BMJ 2000 320 : 1441.
16. Sheikh A, Alves B. Age, sex, geographical and socio-economic variations in admissions for anaphylaxis: analysis of four years of English hospital data. Clin Exp Allergy 2001 31 : 1571 1576.
17. Gupta R, Sheikh A, Strachan DP, Anderson HR. Burden of allergic disease in the UK: secondary analyses of national databases. Clin Exp Allergy 2004 34 : 520 526.
18. Gupta R, Sheikh A, Strachan DP, Anderson HR. Time trends in allergic disorders in the UK. Thorax 2007 62 : 91 96.
19. Reed SD, Lee TA, Mc Crory DC. The economic burden of allergic rhinitis: a critical evaluation of the literature. J Allergy Clin Immunol 2003 111 : 296 300.
20. Arrigo C. Epidemiology and economics of allergy treatment. Clin Exp Allergy 2005 5 : 36 39.
21. Miles S, Fordham R, Mills C, Valovirta E, Mugford M,. A framework for measuring costs to society of IgE-mediated food allergy. Allergy 2005 60 : 996 1003.
22. Project Team of the Resuscitation Council. Emergency medical treatment of anaphylactic reactions. J Accid Emerg Med 1999 16 : 243 247.
23. Walker S, Sheikh A. Managing anaphylaxis: effective emergency and long-term care are necessary. Clin Exp Allergy 2003 33 : 1015 1018.
24. Saracino M. L'absentéisme en Entreprise: un Handicap Réel. Grenoble : ESC Wesford, Section Commercial Management 2005.
25. De Jong V, Rogiers L. Recul de l'absentéisme pour cause de maladie en Belgique: première fois en trois ans. SD Worx 2005. http://www.statbel.gov.be ; accessed 11 January 2007.
26. Moneret-Vautrin DA. Concept d'allergo-vigilance: activité du Réseau d'Allergo Vigilance. Rev Méd Interne 2006 27 : S70 S72.
27. Morisset M, Boulègue M, Beaudouin E, Pirson F, Rancé F, Gallen C et al. Anaphylaxie alimentaire sévère et léthale: cas rapportés en 2002 par le Réseau d'allergovigilance. Rev Fr Allergol Immunol Clin 2003 43 : 480 485.
28. Moneret Vautrin DA, Romano MC, Kanny G, Morisset M, Beaudouin E, Parisot L et al. Le projet d'accueil individualisé (PAI) pour urgence allergique. Presse Méd 2003 32 : 61 66.
29. Didier A, Moneret-Vautrin DA, Scheinmann P, Bloch-Morot E, Dhivert-Donadieu H, Wessel F et al. Commission tripartite. Conditions d'établissement d'un projet d'accueil individualisé en cas de risque d'urgences allergiques alimentaires. Rev Fr Allergol Immunol Clin 2003 43 : 415 418.
30. Sheikh A, Ten Broek V, Brown S, Simons F. H1-antihistamines for the treatment of anaphylaxis with and without shock. Cochrane Database Syst Rev (1) 2007 CD006160.
31. Ellis AK, Day JH. Incidence and characteristics of biphasic anaphylaxis: a prospective evaluation of 103 patients. Ann Allergy Asthma Immunol 2007 98 : 64 69.
32. Clark S, Bock SA, Gaeta TJ, Brenner BE, Cydulka RK, Camargo CA. Multicenter study of emergency department visits for food allergies. J Allergy Clin Immunol 2004 113 : 347 352.
33. Sampson HA. Food allergy - accurately identifying clinical reactivity. Allergy 2005 60 : 19 24.
34. ANAES. Indications du Dosage des IgE Spécifiques Dans le Diagnostic et le Suivi des Maladies Allergiques. Rapport diffusé par la Haute Autorité de Santé. Saint Denis : Haute Autorité de Santé, 2005.
35. Schwartz LB. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin North Am 2006 26 : 451 463.
36. Demoly P. Anaphylactic reactions value of skin and provocation tests. Toxicology 2005 209 : 221 223.
37. Charpin D, Birnbaum J, Vervloet D. Epidemiology of Hymenoptera allergy. Clin Exp Allergy 1994 24 : 1010 1015.
38. Ludolph-Hauser D, Rüeff F, Fries C, Schöpf P, Przybilla B. Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings. Lancet 2001 357 : 361 362.
39. Rueff F, Placzek M, Przybilla B. Mastocytosis and Hymenoptera venom allergy. Curr Opin Allergy Clin Immunol 2006 6 : 284 288.
40. Mertes PM, Laxenaire MC. Anaphylactic and anaphylactoid reactions occurring during anaesthesia in France. Seventh epidemiologic survey (January 2001-December 2002). Ann Fr Anesth Reanim 2004 23 : 1133 1143.
41. Harboe T, Guttormsen AB, Irgens A, Dybendal T, Florvaag E. Anaphylaxis during anesthesia in Norway: a 6-year single-center follow-up study. Anesthesiology 2005 445 : 897 903.
42. Dexter F, Gan TJ, Naguib M, Lubarsky DA. Cost identification analysis for succinylcholine. Anesth Analg 2001 92 : 693 699.
43. Agence Technique de l'Information sur l'hospitalisation. http://www.atih.sante.fr ; accessed 11 January 2007.
44. Sicot C, Laxenaire MC. Lethal anaphylaxis shock due to antibioprophylaxis for proctologic surgery - or a disorganised team work without guidelines. Ann Fr Anesth Reanim 2007 26 : 97 100.
45. Joanne NG, Elberink JN. Significance and rationale of studies of health-related quality of life in anaphylactic disorders. Curr Opin Allergy Clin Immunol 2006 6 : 298 302.
46. Clark S, Gaeta T, Kamarthi GS, Camargo CA. ICD-9-CM coding of emergency visits for food and insect sting allergy. Ann Epidemiol 2006 16 : 696 700.
47. Warner JO. Anaphylaxis: the latest epidemic. Pediatr Allergy Immunol 2007 18 : 1 2.
48. Pumphrey R, Gowland H. Further fatal allergic reactions to food in the United Kingdom 1999-2006. J All Clin Immunol 2007 119 : 1018 1019.
49. Phillips E, Louie M, Knowles SR, Simor AE, Oh PI. Cost-effectiveness analysis of six strategies for cardiovascular surgery prophylaxis in patients labeled penicillin allergic. Am J Health Syst Pharm 2000 57 : 339 345.
50. Park M, Markus P, Matesic D, Li JT. Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy. Ann Allergy Asthma Immunol 2006 97 : 681 687.
51. Krasnick J, Patterson R, Harris KE. Idiopathic anaphylaxis: long-term follow-up, cost and outlook Allergy 1996 51 : 724 731.